Sean Lee
Stock Analyst at HC Wainwright & Co.
(1.87)
# 1098
Out of 5,329 analysts
106
Total ratings
36.92%
Success rate
28.97%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DWTX Dogwood Therapeutics | Upgrades: Buy | 10 | 5.38 | 85.87% | 1 | Apr 23, 2025 | |
ATEC Alphatec Holdings | Reiterates: Buy | 20 20 | 11.13 | 79.69% | 12 | Apr 14, 2025 | |
CASI CASI Pharmaceuticals | Maintains: Buy | 6 4 | 1.99 | 101.01% | 8 | Apr 9, 2025 | |
CTSO CytoSorbents | Reiterates: Neutral | 1 1 | 1.04 | -3.85% | 12 | Apr 3, 2025 | |
MNPR Monopar Therapeutics | Reiterates: Buy | 40 40 | 43.09 | -7.17% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 6 | 0.65 | 746.15% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 3.51 | 213.39% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 7.46 | 34.05% | 13 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 10 | 4.75 | 100% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 5 | n/a | n/a | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | 3.93 | 2444.53% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 1.39 | 2058.27% | 1 | Dec 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 19, 2021 |